BHC
Bowen Hanes & Co’s Novartis NVS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-4,745
| Closed | -$415K | – | 161 |
|
2021
Q4 | $415K | Hold |
4,745
| – | – | 0.01% | 137 |
|
2021
Q3 | $388K | Hold |
4,745
| – | – | 0.01% | 134 |
|
2021
Q2 | $433K | Hold |
4,745
| – | – | 0.01% | 127 |
|
2021
Q1 | $406K | Hold |
4,745
| – | – | 0.01% | 127 |
|
2020
Q4 | $448K | Sell |
4,745
-3,435
| -42% | -$324K | 0.01% | 122 |
|
2020
Q3 | $711K | Sell |
8,180
-1,125
| -12% | -$97.8K | 0.03% | 109 |
|
2020
Q2 | $813K | Sell |
9,305
-791
| -8% | -$69.1K | 0.03% | 97 |
|
2020
Q1 | $832K | Buy |
10,096
+1,000
| +11% | +$82.4K | 0.04% | 96 |
|
2019
Q4 | $861K | Hold |
9,096
| – | – | 0.04% | 111 |
|
2019
Q3 | $790K | Sell |
9,096
-400
| -4% | -$34.7K | 0.03% | 113 |
|
2019
Q2 | $867K | Buy |
9,496
+3,440
| +57% | +$314K | 0.04% | 108 |
|
2019
Q1 | $582K | Buy |
6,056
+126
| +2% | +$12.1K | 0.03% | 115 |
|
2018
Q4 | $509K | Sell |
5,930
-4,520
| -43% | -$388K | 0.03% | 140 |
|
2018
Q3 | $900K | Buy |
+10,450
| New | +$900K | 0.04% | 104 |
|
2016
Q1 | – | Sell |
-51,345
| Closed | -$4.42M | – | 139 |
|
2015
Q4 | $4.42M | Sell |
51,345
-236,500
| -82% | -$20.3M | 0.25% | 80 |
|
2015
Q3 | $26.5M | Sell |
287,845
-51,125
| -15% | -$4.7M | 1.52% | 21 |
|
2015
Q2 | $33.3M | Buy |
338,970
+35
| +0% | +$3.44K | 1.66% | 8 |
|
2015
Q1 | $33.4M | Buy |
338,935
+4,280
| +1% | +$422K | 1.61% | 9 |
|
2014
Q4 | $31M | Sell |
334,655
-6,615
| -2% | -$613K | 1.52% | 14 |
|
2014
Q3 | $32.1M | Sell |
341,270
-50,745
| -13% | -$4.78M | 1.57% | 10 |
|
2014
Q2 | $35.5M | Buy |
392,015
+10,005
| +3% | +$906K | 1.65% | 8 |
|
2014
Q1 | $32.5M | Buy |
382,010
+5,205
| +1% | +$443K | 1.57% | 11 |
|
2013
Q4 | $30.3M | Sell |
376,805
-7,550
| -2% | -$607K | 1.47% | 19 |
|
2013
Q3 | $29.5M | Sell |
384,355
-12,120
| -3% | -$930K | 1.51% | 13 |
|
2013
Q2 | $28M | Buy |
+396,475
| New | +$28M | 1.5% | 19 |
|